000 -LEADER |
fixed length control field |
01980 a2200265 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
041203s xx 000 0 eng |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1522-3264; |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
AC1.S5 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
050 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Timmerman, Luke, |
245 #0 - TITLE STATEMENT |
Title |
Practical Geniuses of Technology--Methodical Man: Ken Mohler. |
Statement of responsibility, etc. |
Luke Timmerman. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Name of publisher, distributor, etc. |
The Seattle Times, |
Date of publication, distribution, etc. |
2004. |
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
SIRS Enduring Issues 2005. |
Number of part/section of a work |
Article 73, |
Name of part/section of a work |
Science, |
International Standard Serial Number |
1522-3264; |
500 ## - GENERAL NOTE |
General note |
Articles Contained in SIRS Enduring Issues 2005. |
500 ## - GENERAL NOTE |
General note |
Originally Published: Practical Geniuses of Technology--Methodical Man: Ken Mohler, May 5, 2004; pp. n.p.. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"Ken Mohler grew up a doctor's son in the Kansas cow town of Abilene. He liked the idea of helping patients--except when doctors felt helpless, out of treatment options. He was more attracted to the can-do mentality of his grandfather, an entrepreneur, and finding ways to apply it to medicine. It took most of his life to do it, starting with years of study in immunology and then a low-level job in a pharmaceutical company, but he found a way. Mohler is one of the few scientists of his generation who has created a breakthrough drug that has enabled bedridden patients to return to their jobs, or play golf, without pain. Mohler, 48, did it at Immunex, one of Seattle's pioneering biotechnology companies, and now runs research and development at a startup, Trubion Pharmaceuticals in Seattle." (THE SEATTLE TIMES) This article examines the work of a scientist whose research led to the relief of pain and suffering for thousands of sufferers of inflammatory diseases such as rheumatoid arthritis. |
599 ## - |
-- |
Records created from non-MARC resource. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Enbrel |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Inflammation |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
General subdivision |
Research |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
Personal name |
Mohler, Ken |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Rheumatoid arthritis |
General subdivision |
Treatment |
710 ## - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
ProQuest Information and Learning Company |
Title of a work |
SIRS Enduring Issues 2005, |
Name of part/section of a work |
Science. |
International Standard Serial Number |
1522-3264; |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
|